Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Technion Israel Institute of Technology: Haifa, Haifa, IL

PI (Immunology)
Employment
Source: Self-asserted source
Yotam Bar-On

Works (3)

Nature is the best designer: A novel variant of oncolytic reovirus

Molecular Therapy: Oncology
2024-09 | Journal article
DOI: 10.1016/j.omton.2024.200865
Contributors: Raghad Khaleafi; Yotam Bar-On
Source: check_circle
Crossref

CLPTM1L is a GPI-anchoring pathway component targeted by HCMV

Journal of Cell Biology
2023-09-04 | Journal article
DOI: 10.1083/jcb.202207104
Contributors: Inbal Kol; Ahmed Rishiq; Mevaseret Cohen; Shira Kahlon; Ophir Pick; Liat Dassa; Natan Stein; Yotam Bar-On; Dana G. Wolf; Einat Seidel et al.
Source: check_circle
Crossref

Nanoparticles presenting clusters of CD4 expose a universal vulnerability of HIV-1 by mimicking target cells

Proceedings of the National Academy of Sciences
2020-08-04 | Journal article
DOI: 10.1073/pnas.2010320117
Contributors: Magnus A. G. Hoffmann; Yotam Bar-On; Zhi Yang; Harry B. Gristick; Priyanthi N. P. Gnanapragasam; Jost Vielmetter; Michel C. Nussenzweig; Pamela J. Bjorkman
Source: check_circle
Crossref

Peer review (4 reviews for 2 publications/grants)

Review activity for Molecular therapy oncolytics. (3)
Review activity for Nature microbiology. (1)
How many people are using ORCID?